Finally, we studied whether there were any relationships between the proportions of NKp30, NKp46, NKG2D, and DNAM-1 expressing peripheral blood NK cells, plasma TGF-β1 levels, and tumor progression. This evidence concerns the gene CD226 and neoplasm.